Why the study?
Sedentary behavior and physical inactivity are leading modifiable risk factors for cardiovascular disease and all-cause mortality, necessitating the promotion of physical activity and exercise training across populations.
Does physical activity and exercise training prevent cardiovascular disease and all-cause mortality compared to sedentary behavior?
Does physical activity and exercise training prevent cardiovascular disease and all-cause mortality compared to sedentary behavior?
This state-of-the-art review emphasizes the critical need to promote physical activity and exercise training to combat the high burden of cardiometabolic diseases associated with sedentary behavior.
Answers are grounded in this paper and cite their sources.
Supports activity promotion amid sedentary risks; leaves open optimal dosing and implementation trials.
Sedentary behavior and physical inactivity are among the leading modifiable risk factors worldwide for cardiovascular disease and all-cause mortality. The promotion of physical activity and exercise training (ET) leading to improved levels of cardiorespiratory fitness is needed in all age groups, race, and ethnicities and both sexes to prevent many chronic diseases, especially cardiovascular disease. In this state-of-the-art review, we discuss the negative impact of sedentary behavior and physical inactivity, as well as the beneficial effects of physical activity /ET and cardiorespiratory fitness for the prevention of chronic noncommunicable diseases, including cardiovascular disease. We review the prognostic utility of cardiorespiratory fitness compared with obesity and the metabolic syndrome, as well as the increase of physical activity /ET for patients with heart failure as a therapeutic strategy, and ET dosing. Greater efforts at preventing sedentary behavior and physical inactivity while promoting physical activity, ET, and cardiorespiratory fitness are needed throughout the healthcare system worldwide and particularly in the United States in which the burden of cardiometabolic diseases remains extremely high.
No takes yet. Share an insight, caveat, or question.
Lavie et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: